echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > How human cells became Zika virus factories

    How human cells became Zika virus factories

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    "Dendritic cells are the primary cells of the innate immune system," said Dr.


    Now, Shresta and his colleagues at LJI and the University of California, San Diego have found that the Zika virus actually forces dendritic cells to stop functioning


    "Dendritic cells do their best to help the virus," Shresta said


    The study in the journal Nature Communications is a big step forward in the work of Shresta's lab in guiding the design of new antiviral therapies for many members of the flavivirus family, including Zika virus, dengue fever, and Japanese encephalitis virus (JEV


    "Understanding how viruses interact with human cells is critical to understanding how infections can be treated or prevented in the future," said Aaron Carlin, a professor at the University of California, San Diego, who is a M.


    Dr.


    Blanche analyzed how gene expression in these dendritic cells changed during Zika or dengue infection


    The researchers found that zika virus manipulates genes


    "We showed that Zika virus (as opposed to dengue) regulates cellular metabolism to increase its replication


    The team then investigated whether zika virus converts other cells into lipid factories


    "These viruses are crazy," Shresta said


    The next step is to develop antiviral drugs that prevent Zika virus from using lipids to metabolize genes


    How to deal with dengue fever, the cousin of Zika virus? Because these viruses are so closely related and overlap in many places, Shresta believes that SREBP inhibitors are just one component in a "cocktail" of inhibitors that treat a variety of different flavivirus infections


    "The more we learn about these viruses, the closer we get to 'yellowing virus' inhibitors


    Journal Reference:

    1. Emilie Branche, Ying-Ting Wang, Karla M.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.